Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 5.47859950 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.47859950 |
3 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.40384948 |
4 | establishment of integrated proviral latency (GO:0075713) | 4.34794885 |
5 | central nervous system myelination (GO:0022010) | 4.29643799 |
6 | axon ensheathment in central nervous system (GO:0032291) | 4.29643799 |
7 | pinocytosis (GO:0006907) | 4.26197553 |
8 | * protein maturation by protein folding (GO:0022417) | 4.19858429 |
9 | synaptic vesicle exocytosis (GO:0016079) | 4.12670178 |
10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.11661370 |
11 | protein retention in ER lumen (GO:0006621) | 4.10191208 |
12 | establishment of viral latency (GO:0019043) | 4.08887070 |
13 | protein localization to endosome (GO:0036010) | 3.91907771 |
14 | barbed-end actin filament capping (GO:0051016) | 3.87355789 |
15 | neuron cell-cell adhesion (GO:0007158) | 3.86812298 |
16 | synaptic vesicle maturation (GO:0016188) | 3.83847537 |
17 | neuronal action potential propagation (GO:0019227) | 3.78653605 |
18 | protein localization to synapse (GO:0035418) | 3.76533228 |
19 | regulation of metalloenzyme activity (GO:0048552) | 3.75238712 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.74355763 |
21 | membrane raft organization (GO:0031579) | 3.73625895 |
22 | vocalization behavior (GO:0071625) | 3.71762537 |
23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.71605864 |
24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.70005924 |
25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.65842188 |
26 | neuron recognition (GO:0008038) | 3.63793908 |
27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.61309694 |
28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.60650516 |
29 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.58324632 |
30 | endothelium development (GO:0003158) | 3.56132190 |
31 | negative regulation of neurotransmitter transport (GO:0051589) | 3.54756702 |
32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.53032632 |
33 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.52954456 |
34 | endothelial tube morphogenesis (GO:0061154) | 3.52240093 |
35 | morphogenesis of an endothelium (GO:0003159) | 3.52240093 |
36 | glutamate receptor signaling pathway (GO:0007215) | 3.51816503 |
37 | angiogenesis involved in wound healing (GO:0060055) | 3.50375856 |
38 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49140682 |
39 | nuclear envelope reassembly (GO:0031468) | 3.47794026 |
40 | mitotic nuclear envelope reassembly (GO:0007084) | 3.47794026 |
41 | positive regulation of actin filament depolymerization (GO:0030836) | 3.43502799 |
42 | glutamate secretion (GO:0014047) | 3.39951914 |
43 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.39279128 |
44 | pentose-phosphate shunt (GO:0006098) | 3.38454708 |
45 | locomotory exploration behavior (GO:0035641) | 3.38265775 |
46 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.35192299 |
47 | regulation of glutamate secretion (GO:0014048) | 3.31300425 |
48 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.30601177 |
49 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.30074433 |
50 | exploration behavior (GO:0035640) | 3.29150119 |
51 | actin filament depolymerization (GO:0030042) | 3.27700988 |
52 | dendritic spine morphogenesis (GO:0060997) | 3.27148145 |
53 | axonal fasciculation (GO:0007413) | 3.25964007 |
54 | dendritic spine organization (GO:0097061) | 3.25916556 |
55 | ATP synthesis coupled proton transport (GO:0015986) | 3.21487811 |
56 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.21487811 |
57 | neuron-neuron synaptic transmission (GO:0007270) | 3.20327186 |
58 | synaptic transmission, glutamatergic (GO:0035249) | 3.17332931 |
59 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.14834644 |
60 | substantia nigra development (GO:0021762) | 3.13572134 |
61 | presynaptic membrane organization (GO:0097090) | 3.12992208 |
62 | skin morphogenesis (GO:0043589) | 3.12858130 |
63 | regulation of synaptic plasticity (GO:0048167) | 3.12822484 |
64 | regulation of synaptic vesicle transport (GO:1902803) | 3.12036453 |
65 | transmission of nerve impulse (GO:0019226) | 3.11937746 |
66 | establishment of mitochondrion localization (GO:0051654) | 3.11066465 |
67 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.09013671 |
68 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.08290220 |
69 | type B pancreatic cell proliferation (GO:0044342) | 3.07608164 |
70 | long-term synaptic potentiation (GO:0060291) | 3.07434433 |
71 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.07210263 |
72 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.06660530 |
73 | myelination (GO:0042552) | 3.05747290 |
74 | regulation of axon regeneration (GO:0048679) | 3.04357377 |
75 | regulation of neuron projection regeneration (GO:0070570) | 3.04357377 |
76 | platelet degranulation (GO:0002576) | 3.04242727 |
77 | hyaluronan catabolic process (GO:0030214) | 3.04021346 |
78 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.03346534 |
79 | positive regulation of lamellipodium assembly (GO:0010592) | 3.03242900 |
80 | ensheathment of neurons (GO:0007272) | 3.03074378 |
81 | axon ensheathment (GO:0008366) | 3.03074378 |
82 | presynaptic membrane assembly (GO:0097105) | 3.02633703 |
83 | proteasome assembly (GO:0043248) | 3.02204128 |
84 | NADPH regeneration (GO:0006740) | 3.00874280 |
85 | negative regulation of protein localization to cell surface (GO:2000009) | 3.00838668 |
86 | regulation of catecholamine metabolic process (GO:0042069) | 2.99503834 |
87 | regulation of dopamine metabolic process (GO:0042053) | 2.99503834 |
88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.98789133 |
89 | negative regulation of microtubule polymerization (GO:0031115) | 2.96939498 |
90 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.93231236 |
91 | behavioral defense response (GO:0002209) | 2.92990238 |
92 | behavioral fear response (GO:0001662) | 2.92990238 |
93 | platelet aggregation (GO:0070527) | 2.91845343 |
94 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.90817303 |
95 | synaptic transmission, dopaminergic (GO:0001963) | 2.89962126 |
96 | cell adhesion mediated by integrin (GO:0033627) | 2.89188262 |
97 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.88868535 |
98 | regulation of postsynaptic membrane potential (GO:0060078) | 2.88808894 |
99 | synaptic vesicle endocytosis (GO:0048488) | 2.88357754 |
100 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.87820740 |
101 | apical protein localization (GO:0045176) | 2.87719339 |
102 | regulation of dendritic spine development (GO:0060998) | 2.87133800 |
103 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.86858624 |
104 | regulation of vesicle fusion (GO:0031338) | 2.86643286 |
105 | regulation of synapse structural plasticity (GO:0051823) | 2.85173122 |
106 | glucose catabolic process (GO:0006007) | 2.84950914 |
107 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84417113 |
108 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.82594091 |
109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.81289590 |
110 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79552401 |
111 | cellular copper ion homeostasis (GO:0006878) | 2.78958586 |
112 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.78781289 |
113 | neuronal ion channel clustering (GO:0045161) | 2.78682409 |
114 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.78441585 |
115 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.78132994 |
116 | fear response (GO:0042596) | 2.77591053 |
117 | hypotonic response (GO:0006971) | 2.76722602 |
118 | mesodermal cell differentiation (GO:0048333) | 2.76149570 |
119 | muscle cell migration (GO:0014812) | 2.75481669 |
120 | innervation (GO:0060384) | 2.74833168 |
121 | long-term memory (GO:0007616) | 2.74624527 |
122 | organelle transport along microtubule (GO:0072384) | 2.74522747 |
123 | chemosensory behavior (GO:0007635) | 2.74347155 |
124 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.73782828 |
125 | long term synaptic depression (GO:0060292) | 2.73037556 |
126 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.72922736 |
127 | stress fiber assembly (GO:0043149) | 2.72861330 |
128 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.72833952 |
129 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.72833952 |
130 | vesicle transport along microtubule (GO:0047496) | 2.71995805 |
131 | wound healing, spreading of epidermal cells (GO:0035313) | 2.71993418 |
132 | layer formation in cerebral cortex (GO:0021819) | 2.70097052 |
133 | substrate-dependent cell migration (GO:0006929) | 2.69759792 |
134 | learning (GO:0007612) | 2.69739366 |
135 | chaperone-mediated protein transport (GO:0072321) | 2.69137571 |
136 | positive regulation of membrane potential (GO:0045838) | 2.68607406 |
137 | GDP-mannose metabolic process (GO:0019673) | 2.67452682 |
138 | negative regulation of amino acid transport (GO:0051956) | 2.65527784 |
139 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.65180378 |
140 | negative regulation of ligase activity (GO:0051352) | 2.65180378 |
141 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.64683995 |
142 | virion assembly (GO:0019068) | 2.63939056 |
143 | detection of calcium ion (GO:0005513) | 2.63683167 |
144 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.63255207 |
145 | positive regulation of dendritic spine development (GO:0060999) | 2.62690241 |
146 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.62258542 |
147 | neuron remodeling (GO:0016322) | 2.62113401 |
148 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.61095308 |
149 | negative regulation of axonogenesis (GO:0050771) | 2.60793078 |
150 | regulation of superoxide anion generation (GO:0032928) | 2.60169664 |
151 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.59265148 |
152 | positive regulation of pseudopodium assembly (GO:0031274) | 2.59015846 |
153 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.58551167 |
154 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.58495606 |
155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.56631086 |
156 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.56022256 |
157 | * extracellular fibril organization (GO:0043206) | 2.55916660 |
158 | fatty acid elongation (GO:0030497) | 2.55461797 |
159 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.55417790 |
160 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.54657392 |
161 | positive regulation of synapse maturation (GO:0090129) | 2.53329688 |
162 | regulation of dendrite morphogenesis (GO:0048814) | 2.52563265 |
163 | positive regulation of macrophage differentiation (GO:0045651) | 2.51660454 |
164 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.51397258 |
165 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50910724 |
166 | positive regulation of lamellipodium organization (GO:1902745) | 2.50748702 |
167 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.50536445 |
168 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.50536445 |
169 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.50416490 |
170 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.50250762 |
171 | basement membrane organization (GO:0071711) | 2.47715667 |
172 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.47133904 |
173 | respiratory electron transport chain (GO:0022904) | 2.46539634 |
174 | ephrin receptor signaling pathway (GO:0048013) | 2.46298947 |
175 | behavioral response to cocaine (GO:0048148) | 2.45229916 |
176 | positive regulation of receptor recycling (GO:0001921) | 2.44918673 |
177 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.43063615 |
178 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.42785018 |
179 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.41823734 |
180 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.41823734 |
181 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.41823734 |
182 | ribosome assembly (GO:0042255) | 2.41057743 |
183 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.40803039 |
184 | vesicle coating (GO:0006901) | 2.40470585 |
185 | negative regulation of stress fiber assembly (GO:0051497) | 2.40223437 |
186 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.39525010 |
187 | cortical actin cytoskeleton organization (GO:0030866) | 2.38390887 |
188 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.38032051 |
189 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.38032051 |
190 | UV protection (GO:0009650) | 2.37101348 |
191 | regulation of mitochondrial membrane potential (GO:0051881) | 2.35439769 |
192 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.33684119 |
193 | regulation of translational termination (GO:0006449) | 2.32521105 |
194 | proline biosynthetic process (GO:0006561) | 2.31887585 |
195 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.31576570 |
196 | lipopolysaccharide metabolic process (GO:0008653) | 2.31421499 |
197 | neutrophil activation involved in immune response (GO:0002283) | 2.30970919 |
198 | pyrimidine-containing compound salvage (GO:0008655) | 2.29227503 |
199 | pyrimidine nucleoside salvage (GO:0043097) | 2.29227503 |
200 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.28798976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.08115143 |
2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.62835660 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50740789 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.32077714 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.25688069 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.21505631 |
7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.83786034 |
8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.81477838 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.81364485 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.81364485 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.81250644 |
12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.75310760 |
13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.71609964 |
14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61655882 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61167973 |
16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.55570812 |
17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.51966725 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.51778590 |
19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46403433 |
20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.43292420 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35254511 |
22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24650309 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22488508 |
24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21850451 |
25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18855196 |
26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.18853004 |
27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06236732 |
28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02386985 |
29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97852577 |
30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.97307597 |
31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93980050 |
32 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91690992 |
33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.88908058 |
34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87958802 |
35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.87932489 |
36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.85124251 |
37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84418212 |
38 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.83567861 |
39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79012253 |
40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.78937872 |
41 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.78409837 |
42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77613665 |
43 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.75452464 |
44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74473395 |
45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73649402 |
46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72700045 |
47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71831306 |
48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70712970 |
49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70642899 |
50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67771853 |
51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66850840 |
52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64469413 |
53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62954062 |
54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.62347481 |
55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61544926 |
56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60254580 |
57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60245318 |
58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60046015 |
59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60017465 |
60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59830938 |
61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58857609 |
62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58782116 |
63 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58699080 |
64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58210177 |
65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.55958891 |
66 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55550478 |
67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55505525 |
68 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.53905243 |
69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53769659 |
70 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53267749 |
71 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52933261 |
72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52690602 |
73 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52299712 |
74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51939742 |
75 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51759442 |
76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49425955 |
77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49319264 |
78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48881972 |
79 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47724733 |
80 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46724802 |
81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45632034 |
82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.45239841 |
83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45214328 |
84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45006091 |
85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44784855 |
86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44543029 |
87 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44168125 |
88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44129088 |
89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43752025 |
90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.42467597 |
91 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42177704 |
92 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42070736 |
93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41904882 |
94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41751237 |
95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.40586313 |
96 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39148437 |
97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39006325 |
98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38906471 |
99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37894036 |
100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35497717 |
101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35186356 |
102 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34961279 |
103 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34917620 |
104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34321514 |
105 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33815384 |
106 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33321865 |
107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32684078 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32533694 |
109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.31965822 |
110 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31375046 |
111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31076271 |
112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30158754 |
113 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29856390 |
114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29761795 |
115 | MYC_22102868_ChIP-Seq_BL_Human | 1.29293928 |
116 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.29250462 |
117 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29189714 |
118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28657842 |
119 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27827544 |
120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26137533 |
121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25575260 |
122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24102154 |
123 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22872928 |
124 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22722062 |
125 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22609993 |
126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20576203 |
127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20404854 |
128 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19897774 |
129 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.19529164 |
130 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19344571 |
131 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18073567 |
132 | JUN_21703547_ChIP-Seq_K562_Human | 1.18062340 |
133 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17547668 |
134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16978367 |
135 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16736316 |
136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15483178 |
137 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15276567 |
138 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15215483 |
139 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14246169 |
140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13918485 |
141 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13745795 |
142 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11801389 |
143 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11801389 |
144 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11496400 |
145 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11260488 |
146 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10901328 |
147 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10550534 |
148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10266814 |
149 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10194000 |
150 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10063350 |
151 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09888680 |
152 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09674960 |
153 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08767713 |
154 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08090437 |
155 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07941913 |
156 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07351317 |
157 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06777271 |
158 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.06690610 |
159 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06527937 |
160 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05482599 |
161 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05036622 |
162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04917464 |
163 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04714148 |
164 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04589757 |
165 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03932980 |
166 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03350259 |
167 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02651085 |
168 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01999609 |
169 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00880884 |
170 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99022119 |
171 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98931771 |
172 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98340493 |
173 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97601596 |
174 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96938103 |
175 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94884109 |
176 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94493152 |
177 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94023063 |
178 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93522402 |
179 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.93249687 |
180 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91652587 |
181 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90744192 |
182 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90441998 |
183 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90239696 |
184 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89141884 |
185 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88589165 |
186 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88558290 |
187 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88175733 |
188 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88175733 |
189 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.88149345 |
190 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87170055 |
191 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.84627372 |
192 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84386745 |
193 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84209646 |
194 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83782812 |
195 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.83661708 |
196 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83585098 |
197 | AR_19668381_ChIP-Seq_PC3_Human | 0.83290287 |
198 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81789303 |
199 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81685911 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.26035157 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.19098926 |
3 | MP0002877_abnormal_melanocyte_morpholog | 3.94586788 |
4 | MP0004270_analgesia | 3.84246208 |
5 | MP0010368_abnormal_lymphatic_system | 3.61693695 |
6 | MP0008438_abnormal_cutaneous_collagen | 3.41751167 |
7 | MP0003635_abnormal_synaptic_transmissio | 3.39950299 |
8 | MP0003566_abnormal_cell_adhesion | 3.39166457 |
9 | MP0005464_abnormal_platelet_physiology | 3.03879502 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.98247904 |
11 | MP0002063_abnormal_learning/memory/cond | 2.83189132 |
12 | MP0009745_abnormal_behavioral_response | 2.80542902 |
13 | MP0001968_abnormal_touch/_nociception | 2.70278455 |
14 | MP0002064_seizures | 2.61596861 |
15 | MP0005058_abnormal_lysosome_morphology | 2.54791597 |
16 | MP0002272_abnormal_nervous_system | 2.44839484 |
17 | MP0003705_abnormal_hypodermis_morpholog | 2.42110655 |
18 | MP0001529_abnormal_vocalization | 2.39471531 |
19 | MP0002572_abnormal_emotion/affect_behav | 2.35167614 |
20 | MP0002736_abnormal_nociception_after | 2.32395793 |
21 | MP0003329_amyloid_beta_deposits | 2.31992414 |
22 | MP0002735_abnormal_chemical_nociception | 2.28332642 |
23 | MP0003279_aneurysm | 2.26820144 |
24 | MP0002734_abnormal_mechanical_nocicepti | 2.18694488 |
25 | MP0000858_altered_metastatic_potential | 2.07325774 |
26 | MP0003122_maternal_imprinting | 2.06464772 |
27 | MP0001879_abnormal_lymphatic_vessel | 2.06310348 |
28 | MP0008260_abnormal_autophagy | 2.04178440 |
29 | MP0005165_increased_susceptibility_to | 2.03371718 |
30 | MP0001486_abnormal_startle_reflex | 2.00257526 |
31 | MP0000920_abnormal_myelination | 1.97139253 |
32 | MP0000778_abnormal_nervous_system | 1.96839971 |
33 | MP0001905_abnormal_dopamine_level | 1.96173061 |
34 | MP0005257_abnormal_intraocular_pressure | 1.95981195 |
35 | MP0003806_abnormal_nucleotide_metabolis | 1.93569990 |
36 | MP0002733_abnormal_thermal_nociception | 1.89558504 |
37 | MP0001440_abnormal_grooming_behavior | 1.89124997 |
38 | MP0006054_spinal_hemorrhage | 1.86009751 |
39 | MP0009046_muscle_twitch | 1.85287390 |
40 | MP0006276_abnormal_autonomic_nervous | 1.83563136 |
41 | MP0000343_altered_response_to | 1.83112465 |
42 | MP0001970_abnormal_pain_threshold | 1.82516710 |
43 | MP0003436_decreased_susceptibility_to | 1.82240076 |
44 | MP0003828_pulmonary_edema | 1.81000187 |
45 | MP0003075_altered_response_to | 1.78095421 |
46 | MP0002822_catalepsy | 1.77217431 |
47 | MP0001853_heart_inflammation | 1.73985782 |
48 | MP0005023_abnormal_wound_healing | 1.68780157 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.64839155 |
50 | MP0002184_abnormal_innervation | 1.64175412 |
51 | MP0005409_darkened_coat_color | 1.63684789 |
52 | MP0004145_abnormal_muscle_electrophysio | 1.58902098 |
53 | MP0005423_abnormal_somatic_nervous | 1.58792173 |
54 | MP0001501_abnormal_sleep_pattern | 1.57233116 |
55 | MP0005451_abnormal_body_composition | 1.56232240 |
56 | MP0002067_abnormal_sensory_capabilities | 1.55497489 |
57 | MP0000013_abnormal_adipose_tissue | 1.53919893 |
58 | MP0005623_abnormal_meninges_morphology | 1.53384158 |
59 | MP0002837_dystrophic_cardiac_calcinosis | 1.47196387 |
60 | MP0000955_abnormal_spinal_cord | 1.47131459 |
61 | MP0004858_abnormal_nervous_system | 1.43670153 |
62 | MP0003091_abnormal_cell_migration | 1.42750861 |
63 | MP0005386_behavior/neurological_phenoty | 1.42388686 |
64 | MP0004924_abnormal_behavior | 1.42388686 |
65 | MP0001542_abnormal_bone_strength | 1.41870099 |
66 | MP0009780_abnormal_chondrocyte_physiolo | 1.40101361 |
67 | MP0005501_abnormal_skin_physiology | 1.39454866 |
68 | MP0003300_gastrointestinal_ulcer | 1.39090127 |
69 | MP0001188_hyperpigmentation | 1.37516948 |
70 | MP0002796_impaired_skin_barrier | 1.37070953 |
71 | MP0004811_abnormal_neuron_physiology | 1.37038333 |
72 | MP0002882_abnormal_neuron_morphology | 1.35913529 |
73 | MP0010352_gastrointestinal_tract_polyps | 1.34769540 |
74 | MP0002060_abnormal_skin_morphology | 1.34560033 |
75 | MP0001533_abnormal_skeleton_physiology | 1.33522908 |
76 | MP0009840_abnormal_foam_cell | 1.32443351 |
77 | MP0003186_abnormal_redox_activity | 1.31363277 |
78 | MP0000767_abnormal_smooth_muscle | 1.30031241 |
79 | MP0003724_increased_susceptibility_to | 1.29773371 |
80 | MP0002066_abnormal_motor_capabilities/c | 1.28577097 |
81 | MP0003303_peritoneal_inflammation | 1.27871795 |
82 | MP0005171_absent_coat_pigmentation | 1.23252336 |
83 | MP0003448_altered_tumor_morphology | 1.22535482 |
84 | MP0002557_abnormal_social/conspecific_i | 1.22331548 |
85 | MP0008007_abnormal_cellular_replicative | 1.21779342 |
86 | MP0009379_abnormal_foot_pigmentation | 1.19553597 |
87 | MP0008569_lethality_at_weaning | 1.18757102 |
88 | MP0001849_ear_inflammation | 1.16537554 |
89 | MP0004885_abnormal_endolymph | 1.16520043 |
90 | MP0000751_myopathy | 1.15240278 |
91 | MP0003634_abnormal_glial_cell | 1.14733075 |
92 | MP0009333_abnormal_splenocyte_physiolog | 1.14650684 |
93 | MP0001958_emphysema | 1.13839588 |
94 | MP0004036_abnormal_muscle_relaxation | 1.12024382 |
95 | MP0002148_abnormal_hypersensitivity_rea | 1.10908589 |
96 | MP0004742_abnormal_vestibular_system | 1.10158664 |
97 | MP0005164_abnormal_response_to | 1.10066477 |
98 | MP0004085_abnormal_heartbeat | 1.09024942 |
99 | MP0001485_abnormal_pinna_reflex | 1.08698578 |
100 | MP0000749_muscle_degeneration | 1.08050648 |
101 | MP0005166_decreased_susceptibility_to | 1.07269628 |
102 | MP0003950_abnormal_plasma_membrane | 1.07071165 |
103 | MP0004142_abnormal_muscle_tone | 1.05952541 |
104 | MP0004272_abnormal_basement_membrane | 1.05688041 |
105 | MP0000249_abnormal_blood_vessel | 1.03142268 |
106 | MP0003633_abnormal_nervous_system | 1.02632629 |
107 | MP0003631_nervous_system_phenotype | 1.01881087 |
108 | MP0000358_abnormal_cell_content/ | 1.01288260 |
109 | MP0005275_abnormal_skin_tensile | 1.01136012 |
110 | MP0008004_abnormal_stomach_pH | 1.01113958 |
111 | MP0009697_abnormal_copulation | 1.00849753 |
112 | * MP0002152_abnormal_brain_morphology | 1.00247963 |
113 | MP0002909_abnormal_adrenal_gland | 0.99929482 |
114 | MP0002419_abnormal_innate_immunity | 0.98619198 |
115 | MP0005621_abnormal_cell_physiology | 0.98305300 |
116 | MP0001835_abnormal_antigen_presentation | 0.98103839 |
117 | MP0004484_altered_response_of | 0.98044149 |
118 | MP0004957_abnormal_blastocyst_morpholog | 0.96711745 |
119 | MP0001915_intracranial_hemorrhage | 0.96015279 |
120 | MP0003172_abnormal_lysosome_physiology | 0.94655475 |
121 | MP0005025_abnormal_response_to | 0.93513129 |
122 | MP0008932_abnormal_embryonic_tissue | 0.93015649 |
123 | MP0002229_neurodegeneration | 0.90900491 |
124 | MP0003453_abnormal_keratinocyte_physiol | 0.90623810 |
125 | MP0005390_skeleton_phenotype | 0.89367470 |
126 | MP0003632_abnormal_nervous_system | 0.87836458 |
127 | MP0000750_abnormal_muscle_regeneration | 0.87466546 |
128 | MP0002752_abnormal_somatic_nervous | 0.85711139 |
129 | MP0000747_muscle_weakness | 0.84883439 |
130 | MP0001243_abnormal_dermal_layer | 0.83689559 |
131 | MP0005000_abnormal_immune_tolerance | 0.83205850 |
132 | MP0001851_eye_inflammation | 0.82890676 |
133 | MP0004947_skin_inflammation | 0.82143478 |
134 | MP0003123_paternal_imprinting | 0.81872515 |
135 | MP0005384_cellular_phenotype | 0.81644157 |
136 | MP0009785_altered_susceptibility_to | 0.81030024 |
137 | MP0001730_embryonic_growth_arrest | 0.80815950 |
138 | MP0001614_abnormal_blood_vessel | 0.80708874 |
139 | MP0000490_abnormal_crypts_of | 0.80703299 |
140 | MP0010386_abnormal_urinary_bladder | 0.79864183 |
141 | MP0005410_abnormal_fertilization | 0.79794030 |
142 | MP0005670_abnormal_white_adipose | 0.79677993 |
143 | MP0000604_amyloidosis | 0.79430914 |
144 | MP0006036_abnormal_mitochondrial_physio | 0.79408956 |
145 | MP0001299_abnormal_eye_distance/ | 0.78672260 |
146 | MP0002998_abnormal_bone_remodeling | 0.78485536 |
147 | MP0005595_abnormal_vascular_smooth | 0.78463253 |
148 | MP0002332_abnormal_exercise_endurance | 0.77958033 |
149 | MP0010030_abnormal_orbit_morphology | 0.77002392 |
150 | MP0009053_abnormal_anal_canal | 0.76356443 |
151 | MP0001216_abnormal_epidermal_layer | 0.76326792 |
152 | MP0004084_abnormal_cardiac_muscle | 0.75877441 |
153 | MP0001963_abnormal_hearing_physiology | 0.75794433 |
154 | MP0003111_abnormal_nucleus_morphology | 0.75700842 |
155 | MP0001502_abnormal_circadian_rhythm | 0.75597060 |
156 | MP0003879_abnormal_hair_cell | 0.75518994 |
157 | MP0005084_abnormal_gallbladder_morpholo | 0.75486645 |
158 | MP0005167_abnormal_blood-brain_barrier | 0.75112355 |
159 | MP0005646_abnormal_pituitary_gland | 0.74713604 |
160 | MP0009763_increased_sensitivity_to | 0.74709327 |
161 | MP0001984_abnormal_olfaction | 0.74464767 |
162 | MP0000350_abnormal_cell_proliferation | 0.74359869 |
163 | MP0002019_abnormal_tumor_incidence | 0.73601302 |
164 | MP0002429_abnormal_blood_cell | 0.73301256 |
165 | MP0004808_abnormal_hematopoietic_stem | 0.73202725 |
166 | MP0003121_genomic_imprinting | 0.73198245 |
167 | MP0002295_abnormal_pulmonary_circulatio | 0.72749212 |
168 | * MP0005620_abnormal_muscle_contractility | 0.71406901 |
169 | MP0004215_abnormal_myocardial_fiber | 0.70604553 |
170 | MP0001664_abnormal_digestion | 0.70335279 |
171 | MP0003786_premature_aging | 0.69165745 |
172 | * MP0005330_cardiomyopathy | 0.68976511 |
173 | MP0010155_abnormal_intestine_physiology | 0.68924295 |
174 | MP0002163_abnormal_gland_morphology | 0.68041698 |
175 | MP0000003_abnormal_adipose_tissue | 0.67867820 |
176 | MP0000631_abnormal_neuroendocrine_gland | 0.67833439 |
177 | MP0003795_abnormal_bone_structure | 0.67749046 |
178 | MP0003787_abnormal_imprinting | 0.67301474 |
179 | * MP0003861_abnormal_nervous_system | 0.66476894 |
180 | MP0003137_abnormal_impulse_conducting | 0.66335342 |
181 | MP0004233_abnormal_muscle_weight | 0.65956122 |
182 | MP0002069_abnormal_eating/drinking_beha | 0.65469627 |
183 | MP0004134_abnormal_chest_morphology | 0.65114612 |
184 | MP0003283_abnormal_digestive_organ | 0.64822283 |
185 | MP0005645_abnormal_hypothalamus_physiol | 0.64150090 |
186 | MP0004510_myositis | 0.63977700 |
187 | MP0001177_atelectasis | 0.63469068 |
188 | MP0002751_abnormal_autonomic_nervous | 0.62339701 |
189 | MP0005187_abnormal_penis_morphology | 0.58422327 |
190 | MP0003385_abnormal_body_wall | 0.58340508 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.41799501 |
2 | Focal motor seizures (HP:0011153) | 5.11789961 |
3 | Premature rupture of membranes (HP:0001788) | 4.67419730 |
4 | Neurofibrillary tangles (HP:0002185) | 4.50807247 |
5 | Cerebral inclusion bodies (HP:0100314) | 4.43099491 |
6 | Protrusio acetabuli (HP:0003179) | 4.07692991 |
7 | Vertebral compression fractures (HP:0002953) | 4.02659221 |
8 | Focal seizures (HP:0007359) | 3.74781898 |
9 | Menorrhagia (HP:0000132) | 3.74380294 |
10 | Supranuclear gaze palsy (HP:0000605) | 3.68627779 |
11 | Visual hallucinations (HP:0002367) | 3.65168164 |
12 | Epileptic encephalopathy (HP:0200134) | 3.50314861 |
13 | Petechiae (HP:0000967) | 3.48143968 |
14 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.36960504 |
15 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.36960504 |
16 | Atonic seizures (HP:0010819) | 3.28297910 |
17 | Pheochromocytoma (HP:0002666) | 3.20074220 |
18 | Distal lower limb muscle weakness (HP:0009053) | 3.18627261 |
19 | Retinal dysplasia (HP:0007973) | 3.11104315 |
20 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.09075914 |
21 | Abnormal platelet function (HP:0011869) | 3.08123996 |
22 | Impaired platelet aggregation (HP:0003540) | 3.08123996 |
23 | Termporal pattern (HP:0011008) | 2.98136101 |
24 | Insidious onset (HP:0003587) | 2.98136101 |
25 | Osteolytic defects of the hand bones (HP:0009699) | 2.97540716 |
26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.97540716 |
27 | Abnormal gallbladder physiology (HP:0012438) | 2.97131652 |
28 | Cholecystitis (HP:0001082) | 2.97131652 |
29 | Dysmetria (HP:0001310) | 2.93802935 |
30 | Distal lower limb amyotrophy (HP:0008944) | 2.92323503 |
31 | Neuroendocrine neoplasm (HP:0100634) | 2.87848105 |
32 | Delusions (HP:0000746) | 2.81156839 |
33 | Amblyopia (HP:0000646) | 2.80723088 |
34 | Acute necrotizing encephalopathy (HP:0006965) | 2.79448183 |
35 | Absence seizures (HP:0002121) | 2.77870600 |
36 | Abnormality of glycolysis (HP:0004366) | 2.77749885 |
37 | Increased serum pyruvate (HP:0003542) | 2.77749885 |
38 | Peripheral hypomyelination (HP:0007182) | 2.75677456 |
39 | Increased mean platelet volume (HP:0011877) | 2.75428411 |
40 | Ankle clonus (HP:0011448) | 2.74587378 |
41 | Amyloidosis (HP:0011034) | 2.71799238 |
42 | Spinal rigidity (HP:0003306) | 2.71675614 |
43 | Anxiety (HP:0000739) | 2.71078035 |
44 | Rough bone trabeculation (HP:0100670) | 2.70687243 |
45 | Abnormality of the corticospinal tract (HP:0002492) | 2.69890398 |
46 | Hyperventilation (HP:0002883) | 2.69659949 |
47 | Purpura (HP:0000979) | 2.69514590 |
48 | Hepatosplenomegaly (HP:0001433) | 2.69335633 |
49 | Epistaxis (HP:0000421) | 2.69138924 |
50 | Dialeptic seizures (HP:0011146) | 2.68468933 |
51 | Abnormal platelet volume (HP:0011876) | 2.67264424 |
52 | Action tremor (HP:0002345) | 2.65914973 |
53 | Progressive cerebellar ataxia (HP:0002073) | 2.62568140 |
54 | Polycythemia (HP:0001901) | 2.62438345 |
55 | Hydroureter (HP:0000072) | 2.59949270 |
56 | Trismus (HP:0000211) | 2.58438024 |
57 | Scanning speech (HP:0002168) | 2.55322498 |
58 | Prolonged bleeding time (HP:0003010) | 2.55168284 |
59 | Upper limb muscle weakness (HP:0003484) | 2.47185450 |
60 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.46295306 |
61 | Megalencephaly (HP:0001355) | 2.44359520 |
62 | Myocardial infarction (HP:0001658) | 2.42835014 |
63 | Vascular tortuosity (HP:0004948) | 2.38130755 |
64 | Increased connective tissue (HP:0009025) | 2.37783279 |
65 | Arterial tortuosity (HP:0005116) | 2.36970007 |
66 | Type II lissencephaly (HP:0007260) | 2.36735465 |
67 | Broad-based gait (HP:0002136) | 2.32280535 |
68 | Achilles tendon contracture (HP:0001771) | 2.31741259 |
69 | Generalized tonic-clonic seizures (HP:0002069) | 2.31352706 |
70 | Thickened helices (HP:0000391) | 2.30164211 |
71 | Progressive macrocephaly (HP:0004481) | 2.28191200 |
72 | Spastic gait (HP:0002064) | 2.28084788 |
73 | Truncal ataxia (HP:0002078) | 2.27578025 |
74 | Upper limb amyotrophy (HP:0009129) | 2.26542883 |
75 | Distal upper limb amyotrophy (HP:0007149) | 2.26542883 |
76 | Axonal loss (HP:0003447) | 2.25346244 |
77 | Aortic dissection (HP:0002647) | 2.24173545 |
78 | Ankle contracture (HP:0006466) | 2.22863154 |
79 | Abnormality of the Achilles tendon (HP:0005109) | 2.22850779 |
80 | Glucose intolerance (HP:0000833) | 2.21365710 |
81 | Atrophic scars (HP:0001075) | 2.20988306 |
82 | Mitochondrial inheritance (HP:0001427) | 2.20080186 |
83 | Cerebral hypomyelination (HP:0006808) | 2.19751506 |
84 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19644748 |
85 | Generalized amyotrophy (HP:0003700) | 2.19292030 |
86 | Sensory axonal neuropathy (HP:0003390) | 2.19205724 |
87 | Nonimmune hydrops fetalis (HP:0001790) | 2.19019058 |
88 | Orthostatic hypotension (HP:0001278) | 2.18628224 |
89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17825472 |
90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17825472 |
91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17825472 |
92 | Rapidly progressive (HP:0003678) | 2.17562336 |
93 | Short nail (HP:0001799) | 2.17197396 |
94 | Dysostosis multiplex (HP:0000943) | 2.16266051 |
95 | Spontaneous hematomas (HP:0007420) | 2.14416793 |
96 | Abnormality of the umbilical cord (HP:0010881) | 2.14114596 |
97 | Depression (HP:0000716) | 2.12705140 |
98 | Cerebral hemorrhage (HP:0001342) | 2.11268807 |
99 | Tetraparesis (HP:0002273) | 2.10146816 |
100 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09067751 |
101 | Lower limb muscle weakness (HP:0007340) | 2.08848649 |
102 | Leukodystrophy (HP:0002415) | 2.06286629 |
103 | Wormian bones (HP:0002645) | 2.04299655 |
104 | Hypertensive crisis (HP:0100735) | 2.03713168 |
105 | Fatigue (HP:0012378) | 2.03653998 |
106 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.03564897 |
107 | Dysdiadochokinesis (HP:0002075) | 2.00483631 |
108 | Cervical subluxation (HP:0003308) | 2.00256918 |
109 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.00174348 |
110 | Poor eye contact (HP:0000817) | 2.00143525 |
111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99159256 |
112 | Onion bulb formation (HP:0003383) | 1.97125357 |
113 | Aortic aneurysm (HP:0004942) | 1.96870213 |
114 | Cardiovascular calcification (HP:0011915) | 1.96174555 |
115 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95769377 |
116 | Hand muscle atrophy (HP:0009130) | 1.95183177 |
117 | Lower limb amyotrophy (HP:0007210) | 1.94781834 |
118 | Acute encephalopathy (HP:0006846) | 1.92601866 |
119 | Hemiparesis (HP:0001269) | 1.92226674 |
120 | Epileptiform EEG discharges (HP:0011182) | 1.91965623 |
121 | Entropion (HP:0000621) | 1.91947419 |
122 | Follicular hyperkeratosis (HP:0007502) | 1.91465118 |
123 | Urinary urgency (HP:0000012) | 1.91422435 |
124 | Blue sclerae (HP:0000592) | 1.90782084 |
125 | Elbow flexion contracture (HP:0002987) | 1.90777776 |
126 | Buphthalmos (HP:0000557) | 1.90612652 |
127 | Joint hemorrhage (HP:0005261) | 1.90579049 |
128 | Vascular calcification (HP:0004934) | 1.90120069 |
129 | Abnormality of macrophages (HP:0004311) | 1.90054579 |
130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89511733 |
131 | Abnormal trabecular bone morphology (HP:0100671) | 1.88727558 |
132 | Steppage gait (HP:0003376) | 1.88294037 |
133 | Sudden death (HP:0001699) | 1.87785861 |
134 | Absent speech (HP:0001344) | 1.87756051 |
135 | Dilatation of the ascending aorta (HP:0005111) | 1.86797594 |
136 | Fasciculations (HP:0002380) | 1.86776256 |
137 | Fragile skin (HP:0001030) | 1.86177821 |
138 | Heterochromia iridis (HP:0001100) | 1.86114391 |
139 | Onycholysis (HP:0001806) | 1.86009065 |
140 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.84220124 |
141 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.84220124 |
142 | Single umbilical artery (HP:0001195) | 1.84220124 |
143 | Dysautonomia (HP:0002459) | 1.83212908 |
144 | Type I transferrin isoform profile (HP:0003642) | 1.83029462 |
145 | Abnormality of binocular vision (HP:0011514) | 1.82724985 |
146 | Diplopia (HP:0000651) | 1.82724985 |
147 | Gingival bleeding (HP:0000225) | 1.81630908 |
148 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.81080080 |
149 | Growth hormone excess (HP:0000845) | 1.80402848 |
150 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79434811 |
151 | Difficulty climbing stairs (HP:0003551) | 1.79274378 |
152 | Polygenic inheritance (HP:0010982) | 1.79045613 |
153 | Autoamputation (HP:0001218) | 1.77478302 |
154 | Progressive inability to walk (HP:0002505) | 1.76749241 |
155 | Spondylolisthesis (HP:0003302) | 1.76484400 |
156 | Postnatal microcephaly (HP:0005484) | 1.75815006 |
157 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.75659953 |
158 | Excessive salivation (HP:0003781) | 1.75546535 |
159 | Drooling (HP:0002307) | 1.75546535 |
160 | Parakeratosis (HP:0001036) | 1.75468294 |
161 | Deep palmar crease (HP:0006191) | 1.75366532 |
162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74225825 |
163 | Psychosis (HP:0000709) | 1.74114492 |
164 | Ulnar claw (HP:0001178) | 1.73695572 |
165 | Intention tremor (HP:0002080) | 1.73678359 |
166 | Generalized myoclonic seizures (HP:0002123) | 1.72972617 |
167 | Nail dystrophy (HP:0008404) | 1.72574041 |
168 | Foot dorsiflexor weakness (HP:0009027) | 1.72370490 |
169 | Hypertriglyceridemia (HP:0002155) | 1.72327914 |
170 | Cerebral aneurysm (HP:0004944) | 1.71976239 |
171 | Abnormality of the foot musculature (HP:0001436) | 1.70734551 |
172 | EEG with generalized epileptiform discharges (HP:0011198) | 1.70681838 |
173 | Nuclear cataract (HP:0100018) | 1.70125733 |
174 | Clumsiness (HP:0002312) | 1.70037348 |
175 | Febrile seizures (HP:0002373) | 1.69155990 |
176 | Interstitial pulmonary disease (HP:0006530) | 1.68526467 |
177 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.68364445 |
178 | Hypokinesia (HP:0002375) | 1.67975437 |
179 | Bruising susceptibility (HP:0000978) | 1.67654291 |
180 | Gaze-evoked nystagmus (HP:0000640) | 1.67130495 |
181 | Abnormal eating behavior (HP:0100738) | 1.67023619 |
182 | Broad face (HP:0000283) | 1.66999719 |
183 | Hepatocellular necrosis (HP:0001404) | 1.66079103 |
184 | Hammertoe (HP:0001765) | 1.65997248 |
185 | Congenital malformation of the right heart (HP:0011723) | 1.65365741 |
186 | Double outlet right ventricle (HP:0001719) | 1.65365741 |
187 | Vaginal atresia (HP:0000148) | 1.63998648 |
188 | Sparse eyelashes (HP:0000653) | 1.63506967 |
189 | Insulin resistance (HP:0000855) | 1.63039557 |
190 | Split foot (HP:0001839) | 1.62984365 |
191 | X-linked dominant inheritance (HP:0001423) | 1.62923708 |
192 | Reduced antithrombin III activity (HP:0001976) | 1.62566932 |
193 | Limb-girdle muscle atrophy (HP:0003797) | 1.62501594 |
194 | Increased CSF lactate (HP:0002490) | 1.60912835 |
195 | Apathy (HP:0000741) | 1.60331603 |
196 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.60214904 |
197 | Genital tract atresia (HP:0001827) | 1.59994440 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.65202064 |
2 | VRK2 | 3.60417147 |
3 | NTRK3 | 3.56017243 |
4 | NME2 | 3.27303133 |
5 | STK39 | 2.74675704 |
6 | MINK1 | 2.61478743 |
7 | MAP3K9 | 2.57329736 |
8 | KSR2 | 2.50030077 |
9 | RIPK4 | 2.46821358 |
10 | ARAF | 2.46370535 |
11 | ERN1 | 2.43102589 |
12 | BCR | 2.40735496 |
13 | PAK4 | 2.35441956 |
14 | NTRK1 | 2.26176600 |
15 | IRAK3 | 2.24521412 |
16 | EPHA2 | 2.19267525 |
17 | PTK2B | 2.19019120 |
18 | PLK2 | 2.16468045 |
19 | LIMK1 | 2.13330895 |
20 | PNCK | 2.09255234 |
21 | MAP3K12 | 2.02890549 |
22 | TGFBR2 | 1.93952162 |
23 | OXSR1 | 1.90676675 |
24 | PIM2 | 1.90357967 |
25 | BUB1 | 1.77395765 |
26 | SCYL2 | 1.75500389 |
27 | PAK6 | 1.75006345 |
28 | CDK19 | 1.73194278 |
29 | EIF2AK1 | 1.72881710 |
30 | MAP3K4 | 1.70750352 |
31 | LMTK2 | 1.70068225 |
32 | KSR1 | 1.69565715 |
33 | UHMK1 | 1.64404362 |
34 | PRKD3 | 1.64326232 |
35 | TAOK2 | 1.62178870 |
36 | SMG1 | 1.58691617 |
37 | WNK4 | 1.54416288 |
38 | MARK1 | 1.45582198 |
39 | CDK14 | 1.44959288 |
40 | CASK | 1.43887360 |
41 | CAMK2B | 1.42792243 |
42 | GRK5 | 1.41639636 |
43 | BMPR2 | 1.37216671 |
44 | MAP2K7 | 1.36991351 |
45 | BCKDK | 1.34029994 |
46 | CDK5 | 1.32371059 |
47 | NME1 | 1.30986139 |
48 | PRPF4B | 1.30023320 |
49 | FGR | 1.28201030 |
50 | CAMK2A | 1.25865437 |
51 | MAP3K11 | 1.24839220 |
52 | MAP3K3 | 1.23354557 |
53 | STK10 | 1.21650585 |
54 | CDK18 | 1.18913723 |
55 | MAP3K13 | 1.18111337 |
56 | TESK2 | 1.17352297 |
57 | MST4 | 1.15868006 |
58 | ROCK2 | 1.15615947 |
59 | LATS2 | 1.13954220 |
60 | CDK15 | 1.12227733 |
61 | MAP2K3 | 1.11866609 |
62 | MST1R | 1.10563399 |
63 | TESK1 | 1.09625099 |
64 | PAK3 | 1.08973953 |
65 | ABL2 | 1.08963778 |
66 | DAPK1 | 1.08553320 |
67 | ZAP70 | 1.06615049 |
68 | RAF1 | 1.05740682 |
69 | CDK11A | 1.00705692 |
70 | CAMK2D | 1.00658587 |
71 | DAPK2 | 0.98734731 |
72 | FER | 0.98307891 |
73 | LRRK2 | 0.96975700 |
74 | MAP3K2 | 0.96967266 |
75 | ERBB4 | 0.96951856 |
76 | FES | 0.95327410 |
77 | MAPKAPK5 | 0.95052373 |
78 | NEK1 | 0.95025298 |
79 | EPHB2 | 0.94865318 |
80 | CDK8 | 0.92107949 |
81 | TYRO3 | 0.91814855 |
82 | TNIK | 0.91295702 |
83 | WNK1 | 0.90657158 |
84 | SIK3 | 0.89320113 |
85 | PRKCG | 0.88573549 |
86 | MAP2K4 | 0.88231073 |
87 | FLT3 | 0.86224383 |
88 | BMX | 0.84038739 |
89 | MET | 0.83873747 |
90 | MAPKAPK3 | 0.80862121 |
91 | DMPK | 0.80377434 |
92 | STK16 | 0.80078425 |
93 | MYLK | 0.79448523 |
94 | PDGFRA | 0.75582486 |
95 | TBK1 | 0.71951190 |
96 | BRAF | 0.71910553 |
97 | PRKCE | 0.71223143 |
98 | DAPK3 | 0.68988618 |
99 | CSNK1G2 | 0.68355069 |
100 | MOS | 0.68262563 |
101 | MAPK13 | 0.66631530 |
102 | MAP3K8 | 0.66344229 |
103 | MAP2K1 | 0.62019451 |
104 | ICK | 0.61987628 |
105 | TRIB3 | 0.61486747 |
106 | CSNK1G3 | 0.61222756 |
107 | MAP3K1 | 0.61028443 |
108 | PRKG2 | 0.59540319 |
109 | CDK7 | 0.59424529 |
110 | CAMK2G | 0.58696759 |
111 | NTRK2 | 0.58602043 |
112 | SRPK1 | 0.57875286 |
113 | SGK494 | 0.56177605 |
114 | SGK223 | 0.56177605 |
115 | DYRK1A | 0.55023485 |
116 | CLK1 | 0.51457606 |
117 | CSNK1A1L | 0.50705180 |
118 | AURKA | 0.50164522 |
119 | MARK2 | 0.49689753 |
120 | NEK6 | 0.49503056 |
121 | PAK2 | 0.49219308 |
122 | DYRK2 | 0.48748858 |
123 | TYK2 | 0.48295651 |
124 | RET | 0.48205897 |
125 | MAPKAPK2 | 0.47965613 |
126 | OBSCN | 0.46981286 |
127 | PKN1 | 0.46150510 |
128 | KDR | 0.45402437 |
129 | EPHB1 | 0.45109393 |
130 | JAK3 | 0.44467818 |
131 | FYN | 0.43565951 |
132 | TTN | 0.43546254 |
133 | CAMKK2 | 0.43232301 |
134 | CDK9 | 0.42995883 |
135 | ILK | 0.42867329 |
136 | BRSK1 | 0.42148278 |
137 | CAMKK1 | 0.41754667 |
138 | PTK2 | 0.41316095 |
139 | PBK | 0.41189437 |
140 | PRKCQ | 0.40883504 |
141 | PDPK1 | 0.40631984 |
142 | CSK | 0.39584195 |
143 | PAK1 | 0.39568451 |
144 | CAMK1 | 0.37050054 |
145 | TIE1 | 0.36404485 |
146 | STK38 | 0.35359842 |
147 | PTK6 | 0.35091290 |
148 | ADRBK1 | 0.34884537 |
149 | GSK3A | 0.34438730 |
150 | PRKD2 | 0.33780626 |
151 | MAPK10 | 0.32142223 |
152 | PRKD1 | 0.31475961 |
153 | PHKG2 | 0.30610189 |
154 | HIPK2 | 0.29734893 |
155 | MAP3K5 | 0.29380464 |
156 | RIPK1 | 0.28349569 |
157 | TEC | 0.25779734 |
158 | NEK9 | 0.24974734 |
159 | SRC | 0.23416080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.83082510 |
2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.70610176 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.44306370 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.35739083 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35229126 |
6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34794358 |
7 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.30445388 |
8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.30152561 |
9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28056327 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.23344044 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.19413712 |
12 | DNA replication_Homo sapiens_hsa03030 | 2.18604971 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12245161 |
14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.11641823 |
15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.09682711 |
16 | Morphine addiction_Homo sapiens_hsa05032 | 2.03453236 |
17 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03320665 |
18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.95448549 |
19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90009916 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89129487 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.87427291 |
22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86557309 |
23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85827383 |
24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.85811629 |
25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84711359 |
26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.81410225 |
27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77534576 |
28 | Salivary secretion_Homo sapiens_hsa04970 | 1.76995554 |
29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75087560 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.73886290 |
31 | Base excision repair_Homo sapiens_hsa03410 | 1.70235764 |
32 | Renin secretion_Homo sapiens_hsa04924 | 1.67038852 |
33 | Bladder cancer_Homo sapiens_hsa05219 | 1.65777796 |
34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.62703087 |
35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58690308 |
36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57686450 |
37 | Axon guidance_Homo sapiens_hsa04360 | 1.57423783 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56396259 |
39 | Taste transduction_Homo sapiens_hsa04742 | 1.54210143 |
40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53843878 |
41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53732460 |
42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.52370136 |
43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52293506 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51814397 |
45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49765083 |
46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.47585528 |
47 | Insulin secretion_Homo sapiens_hsa04911 | 1.46863550 |
48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.46759168 |
49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44329649 |
50 | Gap junction_Homo sapiens_hsa04540 | 1.41608562 |
51 | Focal adhesion_Homo sapiens_hsa04510 | 1.36391849 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36246416 |
53 | Mismatch repair_Homo sapiens_hsa03430 | 1.35925846 |
54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31650666 |
55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28990051 |
56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27692710 |
57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27661158 |
58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25492803 |
59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.25003192 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24651771 |
61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22718952 |
62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.19314969 |
63 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18384797 |
64 | Lysosome_Homo sapiens_hsa04142 | 1.17307351 |
65 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16669729 |
66 | Melanogenesis_Homo sapiens_hsa04916 | 1.16074106 |
67 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.13715706 |
68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06851693 |
69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05355639 |
70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03992826 |
71 | Protein export_Homo sapiens_hsa03060 | 1.03260310 |
72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01913501 |
73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01876784 |
74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00720033 |
75 | Apoptosis_Homo sapiens_hsa04210 | 1.00467714 |
76 | Glioma_Homo sapiens_hsa05214 | 0.98592819 |
77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98508946 |
78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98241386 |
79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96643552 |
80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96511691 |
81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94977651 |
82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93556553 |
83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92592195 |
84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92179840 |
85 | Platelet activation_Homo sapiens_hsa04611 | 0.90580087 |
86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90317815 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90250805 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90086292 |
89 | Phototransduction_Homo sapiens_hsa04744 | 0.89233886 |
90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87104245 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86898322 |
92 | Adherens junction_Homo sapiens_hsa04520 | 0.84331439 |
93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83574590 |
94 | Pertussis_Homo sapiens_hsa05133 | 0.83284094 |
95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83079680 |
96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81999207 |
97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81784367 |
98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.80156608 |
99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80034729 |
100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79951923 |
101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78702686 |
102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78363939 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.76871786 |
104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76653835 |
105 | Tight junction_Homo sapiens_hsa04530 | 0.76289049 |
106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74747266 |
107 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74615413 |
108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74441737 |
109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74169164 |
110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71179252 |
111 | RNA polymerase_Homo sapiens_hsa03020 | 0.68409896 |
112 | Endocytosis_Homo sapiens_hsa04144 | 0.67983738 |
113 | Legionellosis_Homo sapiens_hsa05134 | 0.67698123 |
114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67384389 |
115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66724051 |
116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66484516 |
117 | Hepatitis B_Homo sapiens_hsa05161 | 0.65922756 |
118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65653127 |
119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65156259 |
120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64693105 |
121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64538584 |
122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64472289 |
123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64026594 |
124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62547311 |
125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62100396 |
126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61740529 |
127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61197463 |
128 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61087114 |
129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60917326 |
130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60248640 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58160493 |
132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58085742 |
133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57443199 |
134 | Spliceosome_Homo sapiens_hsa03040 | 0.57019093 |
135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56421326 |
136 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56246304 |
137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56017520 |
138 | Shigellosis_Homo sapiens_hsa05131 | 0.55967331 |
139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55902695 |
140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55884581 |
141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55287046 |
142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55207722 |
143 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55008218 |
144 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54882064 |
145 | Malaria_Homo sapiens_hsa05144 | 0.53272362 |
146 | Cell cycle_Homo sapiens_hsa04110 | 0.52913185 |
147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52463761 |
148 | Tuberculosis_Homo sapiens_hsa05152 | 0.51838390 |
149 | Influenza A_Homo sapiens_hsa05164 | 0.50500502 |
150 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50099331 |
151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49549674 |
152 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48825059 |
153 | Proteasome_Homo sapiens_hsa03050 | 0.47507914 |
154 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46976721 |
155 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46684028 |
156 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46664982 |
157 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46549671 |
158 | Alcoholism_Homo sapiens_hsa05034 | 0.45443909 |
159 | Measles_Homo sapiens_hsa05162 | 0.45077786 |
160 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43985216 |
161 | Purine metabolism_Homo sapiens_hsa00230 | 0.43709994 |
162 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43258232 |
163 | Prion diseases_Homo sapiens_hsa05020 | 0.42616431 |
164 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40646454 |
165 | Salmonella infection_Homo sapiens_hsa05132 | 0.40590274 |
166 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40359206 |
167 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39632603 |
168 | Phagosome_Homo sapiens_hsa04145 | 0.39318970 |
169 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38707517 |
170 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38525014 |
171 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38094704 |
172 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38027054 |
173 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.34787870 |
174 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33788549 |
175 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29602729 |